University of Nebraska Medical Center
University of Nebraska Medical Center

What's going on with RCDToP

In the News

Regents approve center for developmental exposure research

This fall, UNMC will launch a new cross-disciplinary research center focused on how gestational exposures to toxic and pharmacologic agents affect fetal or early childhood neurodevelopment. On Friday, April 24, the University of Nebraska Board of Regents approved creating the Research Center for Developmental Toxicology and Pharmacology. Pending approval by the Coordinating Commission for Postsecondary Education, the RCDToP will be administered by UNMC’s Department of Pharmacology and Experimental Neuroscience in the UNMC College of Medicine.

April 27, 2026

Dr. Aditya Bade

Dr. Bade receives $2.86 million NIH grant

Aditya Bade, PhD, assistant professor in the UNMC Department of Pharmacology and Experimental Neuroscience, recently received a five-year, $2.86 million grant to study effects of HIV-1 medicines on neurodevelopment during pregnancy. The grant, from the National Institutes of Health’s Eunice Kennedy Shriver National Institute of Child Health and Human Development, is Dr. Bade’s first R01 grant. Dr. Bade, a UNMC graduate, has been on faculty for two years, making this a relatively early-career R01 approval. According to NIH statistics, Dr. Bade is a decade younger than the national mean age for researchers to achieve their first NIH R01 or equivalent award.

July 17, 2024

Dr. Aditya Bade